Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Acer Therapeutics Inc. (NASDAQ: ACER).

Full DD Report for ACER

You must become a subscriber to view this report.


Recent News from (NASDAQ: ACER)

Your Daily Pharma Scoop: Galectin Phase 3 Trial, Acer NDA, Chiasma SPA Amendments
Analysis focus: GALT Galectic (GALT) was our focus ticker in one of the articles in the NASH series we did in February. There, we discussed what makes Galectin stand out among the NASH companies. First, it is not a one-trick pony and has a diverse pipeline outside NASH. Second, unlike Genf...
Source: SeekingAlpha
Date: May, 15 2018 10:00
Acer Therapeutics EPS of -$0.11
Acer Therapeutics (NASDAQ: ACER ): Q1 EPS of -$0.11 may not be comparable to consensus of -$0.69. Cash, cash equivalents and securities available-for-sale of $22.1M Press Release More news on: Acer Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, ,
Source: SeekingAlpha
Date: May, 14 2018 16:28
Acer Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
Acer continues progression from development to potential commercialization of EDSIVO™ Company appoints Chief Legal Officer and 3 new VPs of Clinical Operations, Program and Alliance Management, and Market Access and Reimbursement NEWTON, Mass., May 14, 2018 (GLOBE NEWSWIRE) ...
Source: GlobeNewswire
Date: May, 14 2018 16:01
Midday Gainers / Losers (04/13/2018)
Gainers: FTFT +64% . HEAR +22% . NETE +18% . INTT +15% . ACER +15% . ISNS +14% . NCNA +13% . PLSE +12% . PXLW +12% . MYND +10% . More news on: Future Fintech Group Inc, Turtle Beach Corporation, Net Element International, Inc., Stocks on the move, , Rea...
Source: SeekingAlpha
Date: April, 13 2018 12:52
New Research Coverage Highlights TOCAGEN INC, Acer Therapeutics, DMC Global, The Providence Service, WEX, and Alexander's - Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, April 02, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of TOCAGEN INC (NASDAQ:TOCA),  Acer Therapeutics Inc. (NASDAQ:ACE...
Source: GlobeNewswire
Date: April, 02 2018 08:25
Acer Therapeutics misses by $0.16
Acer Therapeutics (NASDAQ: ACER ): Q4 EPS of -$0.63 misses by $0.16 . Cash and equivalents of $15.6M Press Release More news on: Acer Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, ,
Source: SeekingAlpha
Date: March, 07 2018 16:36
Acer Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update
NEWTON, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare diseases with critical unmet medical need, today reported financial res...
Source: GlobeNewswire
Date: March, 07 2018 16:01
Acer Therapeutics to Present at the 30th Annual ROTH Conference
NEWTON, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare diseases with critical unmet medical need, today announced that Chris S...
Source: GlobeNewswire
Date: March, 06 2018 08:30
Acer Therapeutics Expands Management Team with the Appointment of Three Executives and One New Key Hire
Company appoints new VPs of Clinical Science, Manufacturing, and Finance and hires new Senior Director of Marketing New hires support Acer’s progression from development to potential commercialization of EDSIVO TM NEWTON, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Acer Therap...
Source: GlobeNewswire
Date: February, 05 2018 08:30
New Research: Key Drivers of Growth for Guess?, Acer Therapeutics, American National Insurance, J P Morgan Chase, Juno Therapeutics, and Allergan - Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Guess?, Inc. (NYSE:GES), Acer Therapeutics, Inc. (NASDAQ:ACER), American ...
Source: GlobeNewswire
Date: February, 01 2018 07:55

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1719.2519.8219.8218.403314,123

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1518,76435,81152.3973Short
2018-08-1417,48223,77473.5341Short
2018-08-1310,09716,06062.8705Short
2018-08-1031,94352,38060.9832Short
2018-08-0924,30958,37841.6407Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ACER.


About Acer Therapeutics Inc. (NASDAQ: ACER)

Logo for Acer Therapeutics Inc. (NASDAQ: ACER)

Not available

 

Contact Information

 

 

Current Management

  • Neil K. Warma / CEO

Current Share Structure

  • Market Cap: $137,802,819 - 05/14/2018
  • Issue and Outstanding: 7,497,433 - 03/01/2018

 


Recent Filings from (NASDAQ: ACER)

Amendment to a previously filed 8-A12B
Filing Type: 8-A12B/AFiling Source: edgar
Filing Date: May, 15 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 14 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 14 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 09 2018
Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Filing Type: 25-NSEFiling Source: edgar
Filing Date: April, 05 2018
Proxy soliciting materials. Revised preliminary material
Filing Type: PRER14AFiling Source: edgar
Filing Date: March, 30 2018
Proxy soliciting materials. Revised preliminary material
Filing Type: PRER14AFiling Source: edgar
Filing Date: March, 28 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: March, 12 2018

 

 


Daily Technical Chart for (NASDAQ: ACER)

Daily Technical Chart for (NASDAQ: ACER)


Stay tuned for daily updates and more on (NASDAQ: ACER)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ACER)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ACER is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of ACER and does not buy, sell, or trade any shares of ACER. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/